Evommune Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| EQT FUND MANAGEMENT S.A R.L. | 05/14/2026 | 4.93 M | $113.33 M | 0.00% | 15.64% |
| RA CAPITAL MANAGEMENT, L.P. | 05/15/2026 | 3.49 M | $80.34 M | 1.04% | 11.09% |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 05/14/2026 | 1.93 M | $44.30 M | 0.00% | 6.11% |
| ANDERA PARTNERS | 05/11/2026 | 1.90 M | $43.62 M | 0.00% | 6.02% |
| RTW INVESTMENTS, LP | 05/15/2026 | 1.50 M | $34.54 M | 17.03% | 4.77% |
| JPMORGAN CHASE & CO | 05/13/2026 | 1.46 M | $32.11 M | 11.50% | 4.63% |
| BIOIMPACT CAPITAL LLC | 05/15/2026 | 1.46 M | $33.47 M | 1,188.12% | 4.62% |
| NAN FUNG GROUP HOLDINGS LTD | 05/14/2026 | 1.44 M | $33.13 M | 0.00% | 4.57% |
| 05/12/2026 | 1.28 M | $29.45 M | 0.00% | 4.06% | |
| EVENTIDE ASSET MANAGEMENT, LLC | 05/15/2026 | 1.21 M | $27.80 M | 25.75% | 3.84% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/15/2026 | 1.12 M | $25.73 M | 43.08% | 3.55% |
| JANUS HENDERSON GROUP PLC | 05/18/2026 | 896.70 K | $20.62 M | 100.00% | 2.84% |
| MARSHALL WACE, LLP | 05/15/2026 | 879.73 K | $20.22 M | -10.98% | 2.79% |
| BAKER BROS. ADVISORS LP | 05/15/2026 | 847.39 K | $19.48 M | 100.00% | 2.69% |
| ALYESKA INVESTMENT GROUP, L.P. | 05/15/2026 | 726.36 K | $16.70 M | 100.00% | 2.30% |
| 06/12/2026 | 678.59 K | $15.60 M | 215.01% | 2.15% | |
| BLACKROCK, INC. | 05/13/2026 | 673.57 K | $15.49 M | 372.88% | 2.14% |
| KYNAM CAPITAL MANAGEMENT, LP | 05/15/2026 | 625.50 K | $14.38 M | 237.23% | 1.98% |
| SECTORAL ASSET MANAGEMENT INC | 05/15/2026 | 589.01 K | $13.54 M | 0.00% | 1.87% |
| VERITION FUND MANAGEMENT LLC | 05/15/2026 | 549.99 K | $12.64 M | -2.69% | 1.74% |
| AMERICAN CENTURY COMPANIES INC | 05/15/2026 | 492.94 K | $11.33 M | 18.08% | 1.56% |
| 05/15/2026 | 455.05 K | $10.46 M | 100.00% | 1.44% | |
| PERCEPTIVE ADVISORS LLC | 05/29/2026 | 448.35 K | $10.31 M | 100.00% | 1.42% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 05/15/2026 | 446.26 K | $10.26 M | -11.94% | 1.42% |
| FREESTONE GROVE PARTNERS LP | 05/15/2026 | 337.29 K | $7.75 M | 100.00% | 1.07% |
| FEDERATED HERMES, INC. | 05/11/2026 | 325.00 K | $7.47 M | 0.00% | 1.03% |
| GREAT POINT PARTNERS LLC | 05/15/2026 | 325.00 K | $7.47 M | 0.00% | 1.03% |
| UBS GROUP AG | 05/05/2026 | 298.38 K | $6.86 M | 8,639.75% | 0.95% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 248.61 K | $5.72 M | 126.46% | 0.79% |
| E FUND MANAGEMENT CO., LTD. | 04/13/2026 | 243.70 K | $5.60 M | 100.00% | 0.77% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 05/15/2026 | 225.00 K | $5.17 M | 80.00% | 0.71% |
| STEMPOINT CAPITAL LP | 05/18/2026 | 193.78 K | $4.39 M | 184.15% | 0.61% |
| 05/14/2026 | 184.06 K | $4.23 M | -19.37% | 0.58% | |
| ADAR1 CAPITAL MANAGEMENT, LLC | 05/18/2026 | 184.06 K | $4.23 M | 0.00% | 0.58% |
| STATE STREET CORP | 05/15/2026 | 179.51 K | $4.13 M | 469.88% | 0.57% |
| MONASHEE INVESTMENT MANAGEMENT LLC | 05/13/2026 | 179.34 K | $4.12 M | -2.13% | 0.57% |
| SEVEN GRAND MANAGERS, LLC | 05/06/2026 | 164.67 K | $3.79 M | 119.56% | 0.52% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 154.32 K | $3.55 M | 150.22% | 0.49% |
| OCTAGON CAPITAL ADVISORS LP | 05/15/2026 | 143.47 K | $3.30 M | -71.31% | 0.46% |
| BLUE OWL CAPITAL HOLDINGS LP | 05/14/2026 | 100.00 K | $2.30 M | 100.00% | 0.32% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 94.95 K | $2.18 M | 51.42% | 0.30% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 05/14/2026 | 93.91 K | $2.16 M | 100.00% | 0.30% |
| AMERIPRISE FINANCIAL INC | 05/15/2026 | 91.43 K | $2.10 M | -12.55% | 0.29% |
| NORTHERN TRUST CORP | 05/14/2026 | 79.76 K | $1.83 M | 252.34% | 0.25% |
| SPHERA FUNDS MANAGEMENT LTD. | 05/15/2026 | 78.23 K | $1.80 M | -52.91% | 0.25% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 72.58 K | $1.67 M | 100.00% | 0.23% |
| 05/08/2026 | 60.99 K | $1.40 M | 100.00% | 0.19% | |
| PROPEL BIO MANAGEMENT, LLC | 05/14/2026 | 55.66 K | $1.28 M | 100.00% | 0.18% |
| EVERSEPT PARTNERS, LP | 05/15/2026 | 54.68 K | $1.26 M | 100.00% | 0.17% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 05/13/2026 | 51.36 K | $1.18 M | 100.00% | 0.16% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Evommune Inc. institutional Ownership - FAQ's
During the previous two years, 91 institutional investors and hedge funds held shares of Evommune Inc.. The most heavily invested institutionals were:
EQT Fund Management S.a r.l.: 4.93 M
RA CAPITAL MANAGEMENT, L.P.: 3.49 M
Pivotal bioVenture Partners Investment Advisor LLC: 1.93 M
Andera Partners: 1.9 M
RTW INVESTMENTS, LP: 1.5 M
JPMORGAN CHASE & CO: 1.46 M
109.68% of Evommune Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 32.42 M shares in the last 24 months. This purchase volume represents approximately $798.50 M in transactions.